Kane Biotech Inc. V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.

TSXV:KNE - Post by User

Kane Biotech Inc.

<< Previous

Bullboard Posts

Next >>

Post by francoisl13on Jun 06, 2023 11:41am

103 Views

Post# 35482532

Upfront payment from ProgenaCare

They should be getting the 500K upfront payment from PregenaCare sooner than later. Then, the next step would be to announced their very first order for Coactiv+.
I wonder how long it will take to get approval in South America (Salud Pharma)....and see orders from there as well.
Mr. Edwards mentioned briefly that he was expecting orders to come in by Q4 of 2023...will see.
GLTA

<< Previous

Bullboard Posts

Next >>

Three point-of-sale stocks you should watch